While oral bioavailability is lower than subcutaneous administration, these studies established that even high oral doses maintained excellent safety profiles, though higher doses (54 mg) were associated with increased gastrointestinal discomfort
AOD-9604 Supplies Needed Plan based on subcutaneous research dosing of 300-500 mcg/day from a 5 mg vial reconstituted with 3.0 mL bacteriostatic water
Related Articles READERS' COMMENTS [7] Please note, only GPs are permitted to add comments to articles People with the neurological symptoms, OR being in risk populations for malabsorption, (elderly, known malabsorption, GIT surgery, alcohol excess), we would check FBC, plus LFT, and other items as perhaps indicated
Loti Labs provides high-purity AOD 9604 manufactured under GMP conditions in USA facilities